1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VIATRIS INC
Viatris Inc
XNAS: VTRS

Viatris Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining f...

Read More
13.82 0.02 (0.14%)
101.75% Gain from 52W Low
3.1M
XNAS Volume

XNAS 18 Mar, 2026 1:47 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Viatris is on 19 Mar 2026 for the purpose of Viatris Investor Event See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Mid Valuation
41.0 / 100
Momentum Score
Technically Neutral
55.4 / 100
Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM
Analyst Price Target
16
1Yr Price target upside is 12%
9 analysts

10

S

10

W

1

O

2

T

SWOT Analysis

Viatris Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..